Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
26.16
+0.18 (0.69%)
Aug 12, 2026, 3:22 PM EDT - Market open
Collegium Pharmaceutical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 129.47 | 231.25 | 70.57 | 238.95 | 173.69 | 186.43 |
Short-Term Investments | - | 155.43 | 92.2 | 71.6 | - | - |
Cash & Short-Term Investments | 129.47 | 386.68 | 162.76 | 310.55 | 173.69 | 186.43 |
Cash Growth | -41.72% | 137.57% | -47.59% | 78.80% | -6.83% | 7.07% |
Accounts Receivable | 285.1 | 211.33 | 228.54 | 179.53 | 183.12 | 105.84 |
Inventory | 113.27 | 40.91 | 35.56 | 32.33 | 46.5 | 17.39 |
Other Current Assets | 80.18 | 52.49 | 55.39 | 15.2 | 16.68 | 5.88 |
Total Current Assets | 608.01 | 691.41 | 482.26 | 537.6 | 419.99 | 315.54 |
Net Property, Plant & Equipment | 14.44 | 16.2 | 20.15 | 22.01 | 26.38 | 27.14 |
Other Intangible Assets | 1,186 | 669.51 | 891.4 | 421.71 | 567.47 | 268.72 |
Goodwill | 190.18 | 145.93 | 162.33 | 133.86 | 133.7 | - |
Other Long-Term Assets | 137.07 | 133.79 | 107.45 | 28.13 | 26.6 | 80.68 |
Total Assets | 2,136 | 1,657 | 1,664 | 1,143 | 1,174 | 692.08 |
Accounts Payable | 9.24 | 10.66 | 3.93 | 8.69 | 3.49 | 4.19 |
Accrued Expenses | 478.1 | 380.73 | 410.77 | 264.9 | 266.62 | 226.21 |
Current Portion of Long-Term Debt | 55 | 29 | 64.58 | 183.33 | 162.5 | 48.35 |
Current Portion of Leases | 1.56 | 1.41 | 1.27 | 0.99 | 1.11 | 0.81 |
Unearned Revenue | 0.67 | 0.67 | - | - | - | - |
Other Current Liabilities | 29.72 | 17.57 | 28.96 | - | - | - |
Total Current Liabilities | 589.86 | 440.03 | 509.51 | 457.92 | 433.73 | 279.57 |
Long-Term Debt | 1,158 | 901.89 | 908.52 | 483.84 | 538.45 | 201.63 |
Long-Term Leases | 3.41 | 4.13 | 5.54 | 6.12 | 7.11 | 7.95 |
Other Long-Term Liabilities | 72.7 | 9.11 | 11.18 | - | - | - |
Total Long-Term Liabilities | 1,234 | 915.13 | 925.24 | 489.96 | 545.56 | 209.58 |
Total Liabilities | 1,824 | 1,355 | 1,435 | 947.88 | 979.29 | 489.15 |
Common Stock | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Treasury Stock | -222.51 | -222.51 | -197.51 | -137.38 | -61.92 | -42.86 |
Additional Paid-in Capital | 636.06 | 624.95 | 590.25 | 565.95 | 538.07 | 502.1 |
Accumulated Other Comprehensive Income | - | 0.32 | 0.06 | 0.01 | - | - |
Retained Earnings | -101.68 | -101.13 | -164 | -233.19 | -281.34 | -256.34 |
Shareholders' Equity | 311.91 | 301.68 | 228.84 | 195.43 | 194.84 | 202.93 |
Total Liabilities & Equity | 2,136 | 1,657 | 1,664 | 1,143 | 1,174 | 692.08 |
Total Debt | 1,218 | 936.43 | 979.91 | 674.28 | 709.18 | 258.75 |
Net Cash (Debt) | -1,088 | -549.75 | -817.15 | -363.74 | -535.49 | -72.32 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -28.63 | -13.85 | -20.21 | -8.70 | -15.83 | -1.76 |
Book Value | 311.91 | 301.68 | 228.84 | 195.43 | 194.84 | 202.93 |
Book Value Per Share | 8.21 | 7.60 | 5.66 | 4.68 | 5.76 | 4.94 |
Tangible Book Value | -1,064 | -513.76 | -824.89 | -360.13 | -506.32 | -65.8 |
Tangible Book Value Per Share | -28.00 | -12.94 | -20.41 | -8.62 | -14.97 | -1.60 |